These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37646034)

  • 1. Function of reactive oxygen species in myeloid-derived suppressor cells.
    Huang J; Zhao Y; Zhao K; Yin K; Wang S
    Front Immunol; 2023; 14():1226443. PubMed ID: 37646034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression.
    Ohl K; Tenbrock K
    Front Immunol; 2018; 9():2499. PubMed ID: 30425715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
    Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
    Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
    Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
    Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
    Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Suppressor Cells in
    Fresno M; Gironès N
    Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
    Shokati E; Safari E
    Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
    Huang W; Liu Y; Luz A; Berrong M; Meyer JN; Zou Y; Swann E; Sundaramoorthy P; Kang Y; Jauhari S; Lento W; Chao N; Racioppi L
    Front Immunol; 2021; 12():754083. PubMed ID: 34712241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.
    Zhao Y; Du J; Shen X
    Front Immunol; 2023; 14():1157537. PubMed ID: 37006306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Dysthe M; Parihar R
    Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy.
    Krishnamoorthy M; Gerhardt L; Maleki Vareki S
    Cells; 2021 May; 10(5):. PubMed ID: 34065010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.
    Joshi S; Sharabi A
    Pharmacol Ther; 2022 Jul; 235():108114. PubMed ID: 35122833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Progress of Granulocytic Myeloid-derived Suppressor Cells 
in Non-small Cell Lung Cancer].
    Yang C; Zhu R; Zhang Y; Ying L; Wang J; Liu P; Su D
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):65-72. PubMed ID: 38296627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.